What's on the Horizon for Chronic Myeloid Leukemia? September 27, 2018 What's on the Horizon for Chronic Myeloid Leukemia? September 27, 2018 Print Glossary [Click here to enlarge.] Topics Covered We invite you to learn more about: Diagnosing chronic myeloid leukemia (CML) Emerging therapies for CML Side-effects management Communicating with your healthcare team Speaker Michael J. Mauro, MD Leader, Myeloproliferative Neoplasms Program Clinical Director, Leukemia Service Attending Physician and Member Memorial Sloan Kettering Cancer Center Professor of Medicine Weill Cornell Medical College New York, NY Audio Replay Your browser does not support the audio element. Program Materials Program Slides Transcript Program Support Support for this program is provided by Bristol-Myers Squibb, Novartis and Takeda Oncology.